Skip to main content
. 2006 Nov 15;18(1):25–34. doi: 10.1007/s00198-006-0274-z

Fig. 5.

Fig. 5

Sensitivity analysis: Rate ratio for fracture in the first year of therapy between patients on risedronate and patients on alendronate; results of the primary analysis and 4 other methods of analyses